IFIH1 and dermatomyositis: Anti-MDA5 is a myositis-specific antibody, and the presence of anti-MDA5 in dermatomyositis is a subtype that is associated with distinctive skin lesions and an increased risk of rapidly progressive interstitial lung disease [3].